Author
Listed:
- Yoshinori Hayashi
(Faculty of Dental Sciences, Kyushu University)
- Saori Morinaga
(Faculty of Dental Sciences, Kyushu University)
- Jing Zhang
(Faculty of Dental Sciences, Kyushu University)
- Yasushi Satoh
(National Defense Medical College)
- Andrea L. Meredith
(University of Maryland School of Medicine)
- Takahiro Nakata
(Faculty of Health Promotional Sciences, Tokoha University)
- Zhou Wu
(Faculty of Dental Sciences, Kyushu University)
- Shinichi Kohsaka
(National Institute of Neuroscience)
- Kazuhide Inoue
(Graduate School of Pharmaceutical Sciences, Kyushu University
AMED-CREST, Japan Agency for Medical Research and Development)
- Hiroshi Nakanishi
(Faculty of Dental Sciences, Kyushu University
AMED-CREST, Japan Agency for Medical Research and Development)
Abstract
Although morphine is a gold standard medication, long-term opioid use is associated with serious side effects, such as morphine-induced hyperalgesia (MIH) and anti-nociceptive tolerance. Microglia-to-neuron signalling is critically involved in pain hypersensitivity. However, molecules that control microglial cellular state under chronic morphine treatment remain unknown. Here we show that the microglia-specific subtype of Ca2+-activated K+ (BK) channel is responsible for generation of MIH and anti-nociceptive tolerance. We find that, after chronic morphine administration, an increase in arachidonic acid levels through the μ-opioid receptors leads to the sole activation of microglial BK channels in the spinal cord. Silencing BK channel auxiliary β3 subunit significantly attenuates the generation of MIH and anti-nociceptive tolerance, and increases neurotransmission after chronic morphine administration. Therefore, microglia-specific BK channels contribute to the generation of MIH and anti-nociceptive tolerance.
Suggested Citation
Yoshinori Hayashi & Saori Morinaga & Jing Zhang & Yasushi Satoh & Andrea L. Meredith & Takahiro Nakata & Zhou Wu & Shinichi Kohsaka & Kazuhide Inoue & Hiroshi Nakanishi, 2016.
"BK channels in microglia are required for morphine-induced hyperalgesia,"
Nature Communications, Nature, vol. 7(1), pages 1-14, September.
Handle:
RePEc:nat:natcom:v:7:y:2016:i:1:d:10.1038_ncomms11697
DOI: 10.1038/ncomms11697
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:7:y:2016:i:1:d:10.1038_ncomms11697. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.